本周 0 次提及
0
社交
新闻
博客
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
6d前
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
